window.dataLayer = window.dataLayer || []; function gtag(){dataLayer.push(arguments);} gtag('js', new Date()); gtag('config', 'G-4PR1PSYQLJ'); Skip to content

Welcome to Discover Pharma! Today is : April 25, 2026

  • News
  • Featured News Archives
    • 12 Days of Christmas
    • Women in Pharma
  • About Us
Contact Us

Technology and platforms

  • Artificial Intelligence,Data Management,Market Access & Commercialization,Technology and platforms

    Inizio Evoke launches Cognitev to support data-led decision making in life sciences commercialization

    Inizio Evoke has launched Cognitev, a data and analytics platform [...]

    October 10, 2025
  • Biologics & Biosimilars,Clinical Development,European biotech,Global health,Hematology,Rare Diseases,Technology and platforms

    Terumo BCT and Hemex Health join forces to improve outcomes for sickle cell patients

    Terumo Blood and Cell Technologies (Terumo BCT), a global medical [...]

    October 10, 2025
  • Biologics & Biosimilars,Clinical Development,Data Management,Drug Development,Pharmaceuticals and therapeutics,Technology and platforms

    Thermo Fisher Scientific launches enterprise-ready Chromeleon 7.4 for chromatography and mass spectrometry

    Thermo Fisher Scientific has introduced Chromeleon 7.4 software, a fully [...]

    October 9, 2025
  • Biologics & Biosimilars,Biotech,Drug Development,Research & Development,Technology and platforms

    Confo Therapeutics secures VLAIO grant to develop ultra-long-acting GPCR antibody therapies

    Confo Therapeutics has been awarded a EUR 1 million grant [...]

    October 8, 2025
  • Cell & Gene Therapy,Clinical Development,Research & Development,Technology and platforms

    Circio unveils data showing 40-fold increase in AAV gene delivery efficiency with circVec technology

    Circio Holding has presented new in vivo data showing its [...]

    October 8, 2025
  • Artificial Intelligence,Biotech,Movers & Shakers,Research & Development,Technology and platforms

    Sapio Sciences appoints Rich Roda as chief financial officer

    Sapio Sciences has appointed Rich Roda as chief financial officer, [...]

    October 6, 2025
  • Artificial Intelligence,Clinical Trials,Digital Health,Movers & Shakers,Technology and platforms

    OptymEdge appoints senior director to lead global roll-out of ACUVERA platform

    OptymEdge has appointed Amy Del Medico as senior director of [...]

    October 6, 2025
  • Digital Health,Global health,Market Access & Commercialization,Movers & Shakers,Patient Centricity,Pharmaceuticals and therapeutics,Technology and platforms

    HeliosX strengthens leadership team to drive global growth and brand innovation

    HeliosX has expanded its senior leadership team with the appointments [...]

    October 2, 2025
  • Artificial Intelligence,Clinical Trials,Digital Health,Drug Development,Global health,Partnerships & Funding,Pharmaceuticals and therapeutics,Technology and platforms

    QuantHealth secures strategic investment from Sanofi Ventures to accelerate AI-driven clinical trials

    QuantHealth, a pioneer in AI-driven clinical trial simulation, has received [...]

    October 1, 2025
  • Digital Health,Global health,Market Access & Commercialization,Partnerships & Funding,Pharmaceuticals and therapeutics,Technology and platforms

    M42 partners with Medical Tourism Association and Mastercard to expand UAE’s global patient reach

    M42, a global health leader leveraging artificial intelligence, technology, and [...]

    October 1, 2025
Previous101112Next

Bringing you the latest industry news and insights every day

Registered Address: Discover Pharma Ltd, 1 Dartmouth Close, Brighton, BN2 4HZ, UK
Company Number: 16239596

  • About Us
  • Contact Us
  • Legal
    • Cookie Policy
    • Privacy Policy
    • Terms & Conditions
  • Author Guidelines
    • Pharmaceutical Author Guidelines
    • Press Release Advice
  • Advertise with Us
  • Media Kit Request

© 2026 Discover Pharma. All rights reserved • Developed by Hairy Goat Design

Page load link

Press “ESC” key to close

main menu
  • Home
  • News
  • About Us
  • Contact
recent posts
  • Orano Med appoints Frederic Desdouits as CEO to advance targeted alpha therapy pipeline
    Categories: Biotech, Healthcare leadership, Movers & Shakers, Oncology, Pharmaceuticals and therapeutics, Research & Development
  • Aravax adds allergy specialists to board as peanut therapy advances
    Categories: Biotech, Clinical Development, Clinical Trials, Healthcare leadership, Immunology, Movers & Shakers
  • AI-derived drug candidate reduces fentanyl intake in preclinical opioid study
    Categories: Artificial Intelligence, Clinical studies, Drug discovery, Neurosciences, Pharmaceuticals and therapeutics
get connected
This website uses cookies and third party services. See our Cookie Policy and Privacy Policy pages for details. OK
Go to Top